GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » YoY Rev. per Sh. Growth

SLS BIO Co (XKRX:246250) YoY Rev. per Sh. Growth : -17.61% (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is SLS BIO Co YoY Rev. per Sh. Growth?

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months. SLS BIO Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 was -17.61%.

SLS BIO Co's Revenue per Share for the three months ended in Mar. 2024 was ₩260.58.

SLS BIO Co YoY Rev. per Sh. Growth Historical Data

The historical data trend for SLS BIO Co's YoY Rev. per Sh. Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SLS BIO Co YoY Rev. per Sh. Growth Chart

SLS BIO Co Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
YoY Rev. per Sh. Growth
Get a 7-Day Free Trial Premium Member Only 10.60 18.15 -11.47 37.61 -18.12

SLS BIO Co Quarterly Data
Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
YoY Rev. per Sh. Growth Get a 7-Day Free Trial - - -17.71 -25.43 -17.61

SLS BIO Co YoY Rev. per Sh. Growth Calculation

YoY Rev. per Sh. Growth is the percentage change of Revenue per Share over the past twelve months.

SLS BIO Co's YoY Rev. per Sh. Growth for the fiscal year that ended in Dec. 2023 is calculated as:

YoY Rev. per Sh. Growth (A: Dec. 2023 )
=(Revenue per Share (A: Dec. 2023 )-Revenue per Share (A: Dec. 2022 ))/ | Revenue per Share (A: Dec. 2022 ) |
=(1283.556-1567.561)/ | 1567.561 |
=-18.12 %

SLS BIO Co's YoY Rev. per Sh. Growth for the quarter that ended in Mar. 2024 is calculated as:

YoY Rev. per Sh. Growth (Q: Mar. 2024 )
=(Revenue per Share (Q: Mar. 2024 )-Revenue per Share (Q: Mar. 2023 )) / | Revenue per Share (Q: Mar. 2023 )) |
=(260.58-316.267)/ | 316.267 |
=-17.61 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

SLS BIO Co YoY Rev. per Sh. Growth Related Terms

Thank you for viewing the detailed overview of SLS BIO Co's YoY Rev. per Sh. Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

SLS BIO Co (XKRX:246250) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » SLS BIO Co Ltd (XKRX:246250) » Definitions » YoY Rev. per Sh. Growth
Comparable Companies
XKRX:303360 XKRX:149300 XKRX:109820 XKRX:086460 XKRX:236340 XKRX:229000 XKRX:347740 XKRX:031860 XKRX:221800 XKRX:245620 TMO DHR SHSE:603259 IDXX IQV A XSWX:LONN MTD ICLR ILMN
Traded in Other Exchanges
N/A
Address
Gwanggyo Central Biz Tower, 7th floor, Changryong-dong 260, Gyeonggi-do, Suwon-si, KOR, 16229
Website
http://www.slabs.co.kr
SLS BIO Co Ltd is engaged in providing drug development supporting services and pharmaceutical product QC through general tests and assays and instrumental analysis.

SLS BIO Co (XKRX:246250) Headlines

No Headlines